Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
2.100
-0.220 (-9.48%)
At close: Mar 31, 2025, 4:00 PM
2.163
+0.063 (2.98%)
After-hours: Mar 31, 2025, 5:32 PM EDT
Curis Market Cap
Curis has a market cap or net worth of $17.78 million as of March 31, 2025. Its market cap has decreased by -70.56% in one year.
Market Cap
17.78M
Enterprise Value
34.91M
1-Year Change
-70.56%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since August 1, 2000, Curis's market cap has decreased from $613.20M to $17.78M, a decrease of -97.10%. That is a compound annual growth rate of -13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 19.60M | -24.32% |
| Dec 31, 2024 | 25.90M | -65.47% |
| Dec 29, 2023 | 75.00M | 41.51% |
| Dec 30, 2022 | 53.00M | -87.85% |
| Dec 31, 2021 | 436.10M | -9.47% |
| Dec 31, 2020 | 481.70M | 754.08% |
| Dec 31, 2019 | 56.40M | 147.37% |
| Dec 31, 2018 | 22.80M | -80.14% |
| Dec 29, 2017 | 114.80M | -73.48% |
| Dec 30, 2016 | 432.90M | 15.87% |
| Dec 31, 2015 | 373.60M | 189.61% |
| Dec 31, 2014 | 129.00M | -46.69% |
| Dec 31, 2013 | 242.00M | -11.78% |
| Dec 31, 2012 | 274.30M | -23.47% |
| Dec 30, 2011 | 358.40M | 139.25% |
| Dec 31, 2010 | 149.80M | -30.74% |
| Dec 31, 2009 | 216.30M | 354.41% |
| Dec 31, 2008 | 47.60M | -23.10% |
| Dec 31, 2007 | 61.90M | -0.16% |
| Dec 29, 2006 | 62.00M | -64.71% |
| Dec 30, 2005 | 175.70M | -28.84% |
| Dec 31, 2004 | 246.90M | 36.11% |
| Dec 31, 2003 | 181.40M | 438.28% |
| Dec 31, 2002 | 33.70M | -81.39% |
| Dec 31, 2001 | 181.10M | -21.84% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.46B |
| UnitedHealth Group | 477.03B |
| Johnson & Johnson | 399.09B |
| AbbVie | 365.90B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 228.63B |
| Merck & Co. | 224.72B |